Press releases
July 4, 2023
Hemerion announces FDA clearance of IND application for its Pentalafen® / Heliance® combination product in the treatment of glioblastoma, the most aggressive primary brain tumor
Read the Press Release
April 12, 2023
Cancer treatment: Hemerion secures an additional €2 million in funding from Bpifrance
Read the Press Release
April 14, 2022
Hemerion Therapeutics successfully raises over €3.5 million: a new hope for the treatment of brain cancer.
Read the Press Release
October 28, 2021
Hemerion and Mount Sinai Hospital awarded the Galien MedStartup Prize for “Best Collaboration in the MedTech and Digital Health” category
Read the Press Release
March 22, 2021
Positive preliminary clinical results for the treatment of glioblastoma developed by Hemerion
Read the Press Release
They talk about us
June 7, 2023
Hemerion makes progress with its laser therapy for brain cancer
April, 2023
Hopes of laser therapy in the battle against brain tumors
September, 2022
Innovative medicine / Light-based treatments
May 05, 2022
Hemerion tests innovative laser therapy for brain cancer
May 02, 2022
How to revolutionize tomorrow’s health care?
March 31, 2022
Glioblastoma: an innovative laser treatment
May, 2022
Hemerion aims to increase survival for brain cancer patients
April 15, 2022
Hemerion takes on glioblastoma
May, 2021
Hemerion on the cover of the May Journal of Neuro-Oncology
April, 2021
Tumor cells destroyed by laser by Hemerion Therapeutics
February 23, 2021
When glioblastoma sees red
February 15, 2021
Hemerion Therapeutics wins award for therapeutic innovation
Resources
Contact
Maximilien Vermandel
Stay tuned to our clinical advances